Department of Medicine, Yale University School of Medicine, New Haven, Connecticut, United States of America.
PLoS One. 2010 Jun 14;5(6):e11088. doi: 10.1371/journal.pone.0011088.
Declining serum concentrations of 25-hydroxyvitamin D seen in the fall and winter as distance increases from the equator may be a factor in the seasonal increased prevalence of influenza and other viral infections. This study was done to determine if serum 25-hydroxyvitamin D concentrations correlated with the incidence of acute viral respiratory tract infections.
METHODOLOGY/FINDINGS: In this prospective cohort study serial monthly concentrations of 25-hydroxyvitamin D were measured over the fall and winter 2009-2010 in 198 healthy adults, blinded to the nature of the substance being measured. The participants were evaluated for the development of any acute respiratory tract infections by investigators blinded to the 25-hydroxyvitamin D concentrations. The incidence of infection in participants with different concentrations of vitamin D was determined. One hundred ninety-five (98.5%) of the enrolled participants completed the study. Light skin pigmentation, lean body mass, and supplementation with vitamin D were found to correlate with higher concentrations of 25-hydroxyvitamin D. Concentrations of 38 ng/ml or more were associated with a significant (p<0.0001) two-fold reduction in the risk of developing acute respiratory tract infections and with a marked reduction in the percentages of days ill.
CONCLUSIONS/SIGNIFICANCE: Maintenance of a 25-hydroxyvitamin D serum concentration of 38 ng/ml or higher should significantly reduce the incidence of acute viral respiratory tract infections and the burden of illness caused thereby, at least during the fall and winter in temperate zones. The findings of the present study provide direction for and call for future interventional studies examining the efficacy of vitamin D supplementation in reducing the incidence and severity of specific viral infections, including influenza, in the general population and in subpopulations with lower 25-hydroxyvitamin D concentrations, such as pregnant women, dark skinned individuals, and the obese.
随着与赤道距离的增加,在秋季和冬季血清 25-羟维生素 D 浓度下降,这可能是流感和其他病毒感染季节性高发的一个因素。本研究旨在确定血清 25-羟维生素 D 浓度是否与急性病毒性呼吸道感染的发生率相关。
方法/结果:在这项前瞻性队列研究中,2009-2010 年秋季和冬季,198 名健康成年人每月进行一次血清 25-羟维生素 D 浓度的连续测量,测量过程对测量物质的性质进行了盲法处理。研究人员对所有参与者进行了急性呼吸道感染的评估,评估人员对 25-羟维生素 D 浓度不知情。根据维生素 D 浓度的不同,确定了感染参与者的感染发生率。195 名(98.5%)入组参与者完成了研究。浅色皮肤色素沉着、瘦体重和维生素 D 补充与较高的 25-羟维生素 D 浓度相关。血清浓度达到 38ng/ml 或更高与发生急性呼吸道感染的风险显著降低(p<0.0001)相关,与患病天数明显减少相关。
结论/意义:维持血清 25-羟维生素 D 浓度达到 38ng/ml 或更高水平,应能显著降低急性病毒性呼吸道感染的发生率和疾病负担,至少在温带地区的秋季和冬季如此。本研究的结果为未来的干预研究提供了方向,这些研究将检验维生素 D 补充在降低普通人群和 25-羟维生素 D 浓度较低的亚人群(如孕妇、深色皮肤人群和肥胖人群)中特定病毒感染(包括流感)的发生率和严重程度方面的疗效。